Sector News

J&J adds 200 jobs with new biopharma plant at site in Ireland

October 8, 2019
Life sciences

Johnson & Johnson’s Janssen has had biopharma operations in Ringaskiddy, Co. Cork for nearly 15 years. Now it has a new $350 million facility and added 200 jobs.

The official opening, which was announced by IDA Ireland, boosted the site’s size by 19,100 square meters (205,590 square feet).

“Our Ringaskiddy facility is an important part of our global manufacturing network and expanding our capabilities here will allow us to pursue innovative solutions …” Kathy Wengel, J&J’s chief global supply chain officer, said in a statement.

The company started on the €300 million project in 2017. The additions included expansion of an existing warehouse, laboratory and administration buildings, and expansion of the wastewater treatment plant to accommodate increased volumes.

At the time the company said the new plant would bolster capacity of APIs for drugs that treat “multiple myeloma, rheumatoid arthritis and Crohn’s disease.” While it didn’t specifically identify the products to be made there, J&J sells blockbuster Remicade for rheumatoid arthritis and Crohn’s disease, as well as Simponi for treating rheumatoid arthritis and Stelara for treating Crohn’s disease.

According to a new forecast from GlobalData, Stelara is expected to be the ninth-best selling drug globally in 2025 with $7.5 billion in sales.

By Eric Palmer

Source: Fierce Pharma

Related News

March 31, 2020

Pandemic sees one-quarter of investigators halting trial enrollment: poll

Life sciences

A new survey by Clinical Research IO has found that nearly one-quarter of polled trial investigators have stopped enrolling new patients due to the COVID-19 pandemic. The survey, conducted March […]

March 27, 2020

EU regulators to propose 1-year MDR delay

Life sciences

Dive Brief: The European Commission is working on a proposal to delay enforcement of the EU Medical Device Regulation by one year, a spokesperson said Wednesday.   Policymakers are aiming […]

March 26, 2020

Turning pharma green: an eco-wish list for the industry

Life sciences

The reality of climate change is hard to ignore. As one of the biggest polluters, and simultaneously the industry tasked with trying to tackle the global health outcomes of environmental […]